Nevena Sečen

897 total citations · 1 hit paper
18 papers, 656 citations indexed

About

Nevena Sečen is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Nevena Sečen has authored 18 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 5 papers in Surgery and 5 papers in Oncology. Recurrent topics in Nevena Sečen's work include Lung Cancer Treatments and Mutations (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Lung Cancer Research Studies (3 papers). Nevena Sečen is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Lung Cancer Research Studies (3 papers). Nevena Sečen collaborates with scholars based in Serbia, Spain and United States. Nevena Sečen's co-authors include Namrata S. Patil, Melissa L. Johnson, A. Patel, Manuel Cobo, Delvys Rodríguez‐Abreu, Maen Hussein, Fabrice Barlési, Bartomeu Massutí, Ki Hyeong Lee and Sandrine Hiret and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Lancet Oncology.

In The Last Decade

Nevena Sečen

18 papers receiving 642 citations

Hit Papers

Tiragolumab plus atezolizumab versus placebo plus atezoli... 2022 2026 2023 2024 2022 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study
    2022 296 citations Byoung Chul Cho, Delvys Rodríguez‐Abreu et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nevena Sečen Serbia 8 443 266 224 65 64 18 656
Kayoko Kibata Japan 12 327 0.7× 193 0.7× 178 0.8× 57 0.9× 81 1.3× 24 616
Kuninobu Kanai Japan 10 435 1.0× 98 0.4× 316 1.4× 53 0.8× 71 1.1× 24 622
Juan I. Pascual Spain 8 158 0.4× 110 0.4× 163 0.7× 66 1.0× 71 1.1× 25 394
Ning Kang China 14 133 0.3× 212 0.8× 105 0.5× 115 1.8× 79 1.2× 45 524
Hanwei Peng China 9 294 0.7× 100 0.4× 66 0.3× 253 3.9× 51 0.8× 34 545
Emmanouil Spanoudakis Greece 13 129 0.3× 258 1.0× 148 0.7× 17 0.3× 125 2.0× 49 599
Yuanyu Qian China 9 330 0.7× 92 0.3× 151 0.7× 212 3.3× 76 1.2× 17 589
Hironori Yamashita Japan 13 159 0.4× 66 0.2× 134 0.6× 182 2.8× 81 1.3× 49 485
Ž Pavletić United States 13 226 0.5× 152 0.6× 83 0.4× 17 0.3× 37 0.6× 22 563

Countries citing papers authored by Nevena Sečen

Since Specialization
Citations

This map shows the geographic impact of Nevena Sečen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nevena Sečen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nevena Sečen more than expected).

Fields of papers citing papers by Nevena Sečen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nevena Sečen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nevena Sečen. The network helps show where Nevena Sečen may publish in the future.

Co-authorship network of co-authors of Nevena Sečen

This figure shows the co-authorship network connecting the top 25 collaborators of Nevena Sečen. A scholar is included among the top collaborators of Nevena Sečen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nevena Sečen. Nevena Sečen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Cho, Byoung Chul, Delvys Rodríguez‐Abreu, Maen Hussein, et al.. (2022). Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study. The Lancet Oncology. 23(6). 781–792. 296 indexed citations breakdown →
2.
3.
4.
Perin, Branislav, et al.. (2017). PUB117 Beta Estrogen Receptor as Potential Prognostic Factor in Lung Adenocarcinoma. Journal of Thoracic Oncology. 12(1). S1515–S1516. 7 indexed citations
5.
Zvezdin, Biljana, et al.. (2017). Impact of inhalation therapy on the incidence of carious lesions in patients with asthma and COPD. Journal of Applied Oral Science. 25(5). 506–514. 24 indexed citations
6.
Jovanović, Dragana, et al.. (2017). Characteristics of lung cancer patients in Serbia and subsequent treatment in advanced NSCLC over time – epidemiology study. Lung Cancer. PA4257–PA4257. 1 indexed citations
7.
Zarogoulidis, Paul, Kaid Darwiche, Lonny Yarmus, et al.. (2014). Defense Mechanisms of the Respiratory System and Aerosol Production Systems. Medicinal Chemistry. 10(2). 123–136. 13 indexed citations
8.
Zarogoulidis, Paul, Ioannis Kioumis, Georgia Pitsiou, et al.. (2014). Pneumothorax: from definition to diagnosis and treatment.. PubMed. 6(Suppl 4). S372–6. 67 indexed citations
9.
Sečen, Nevena, et al.. (2012). Actinomyces Odontolyticus - Associated Bacteremia. Macedonian Journal of Medical Sciences. 5(3). 1 indexed citations
10.
Sečen, Nevena, et al.. (2012). Actinomyces Odontolyticus - Associated Bacteremia. Macedonian Journal of Medical Sciences. 5(3). 324–327. 3 indexed citations
11.
Sečen, Nevena, et al.. (2011). Effect of cardiovascular comorbidities on the survival patients with stage I and II non-small-cell lung cancer. European Respiratory Journal. 38(Suppl 55). p2819–p2819. 1 indexed citations
12.
Zarić, Bojan, et al.. (2011). Clinical trials in advanced stage lung cancer: a survey of patients' opinion about their treatment. SHILAP Revista de lepidopterología. 6(1). 20–20. 5 indexed citations
13.
Sečen, Nevena, et al.. (2011). Atelectasis: positive or negative prognostic factor on outcome of patients with non-small cell lung cancer?. PubMed. 15(4). 679–83. 1 indexed citations
14.
Sečen, Nevena, et al.. (2009). Frequency and relevance of concomitant diseases in elderly patients hospitalized for community acquired pneumonia. Srpski arhiv za celokupno lekarstvo. 137(11-12). 619–626. 3 indexed citations
15.
Sečen, Nevena, et al.. (2008). Influence of dexamethasone on appetite and body weight in lung cancer patients. Medicinski pregled. 61(11-12). 571–575. 16 indexed citations
16.
Sečen, Nevena, et al.. (2008). Aprepitant--where do we stand in the control of chemotherapy-induced nausea and vomiting?. PubMed. 13(3). 333–9. 5 indexed citations
17.
Sečen, Nevena, et al.. (2007). The influence of dexamethasone in the decrease of chemotherapy-induced nausea and vomiting.. PubMed. 12(2). 245–52. 1 indexed citations
18.
Sečen, Nevena, et al.. (1991). [Sarcoidosis activity markers].. PubMed. 44(5-6). 259–62. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kayoko Kibata Breakdown of academic impact, for papers by Kuninobu Kanai Breakdown of academic impact, for papers by Juan I. Pascual Breakdown of academic impact, for papers by Ning Kang Breakdown of academic impact, for papers by Hanwei Peng Breakdown of academic impact, for papers by Emmanouil Spanoudakis Breakdown of academic impact, for papers by Yuanyu Qian Breakdown of academic impact, for papers by Hironori Yamashita Breakdown of academic impact, for papers by Ž Pavletić
Rankless by CCL
2026